Suppr超能文献

大肠杆菌无症状菌尿菌株83972的分子特征:病原菌的驯化

Molecular characterization of the Escherichia coli asymptomatic bacteriuria strain 83972: the taming of a pathogen.

作者信息

Klemm Per, Roos Viktoria, Ulett Glen C, Svanborg Catharina, Schembri Mark A

机构信息

School of Molecular and Microbial Sciences, Building 76, University of Queensland, Brisbane QLD 4072, Australia.

出版信息

Infect Immun. 2006 Jan;74(1):781-5. doi: 10.1128/IAI.74.1.781-785.2006.

Abstract

Escherichia coli 83972 is a clinical asymptomatia bacteriuric isolate that is able to colonize the human urinary bladder without inducing an immune response. Here we demonstrate that one of the mechanisms by which this strain has become attenuated is through the mutation of its genes encoding type 1 and P fimbriae.

摘要

大肠杆菌83972是一种临床无症状菌尿分离株,能够在人类膀胱中定殖而不引发免疫反应。在此我们证明,该菌株减毒的机制之一是其编码1型菌毛和P菌毛的基因突变。

相似文献

2
Virulence properties of Escherichia coli 83972, a prototype strain associated with asymptomatic bacteriuria.
Infect Immun. 1999 Jan;67(1):429-32. doi: 10.1128/IAI.67.1.429-432.1999.
3
P fimbriae enhance the early establishment of Escherichia coli in the human urinary tract.
Mol Microbiol. 2000 Nov;38(3):456-64. doi: 10.1046/j.1365-2958.2000.02165.x.
5
The role of P fimbriae for colonization and host response induction in the human urinary tract.
J Infect Dis. 2001 Mar 1;183 Suppl 1:S43-6. doi: 10.1086/318849.

引用本文的文献

1
Competitive fitness of asymptomatic bacteriuria strain 83972 against uropathogens in human urine.
Infect Immun. 2024 Jun 11;92(6):e0017324. doi: 10.1128/iai.00173-24. Epub 2024 May 23.
2
Competitive Inoculation as an Effective Prophylaxis Against Recurrent Urinary Tract Infections: A Systematic Review.
Int Neurourol J. 2023 Jun;27(2):79-87. doi: 10.5213/inj.2346052.026. Epub 2023 Jun 30.
3
Urinary Tract Infection and Microbiome.
Diagnostics (Basel). 2023 May 31;13(11):1921. doi: 10.3390/diagnostics13111921.
6
The microbiome and host mucosal interactions in urinary tract diseases.
Mucosal Immunol. 2021 Jul;14(4):779-792. doi: 10.1038/s41385-020-00372-5. Epub 2021 Feb 4.
7
Pathogenicity Factors of Genomic Islands in Intestinal and Extraintestinal .
Front Microbiol. 2020 Sep 25;11:2065. doi: 10.3389/fmicb.2020.02065. eCollection 2020.
9
Fimbriae reprogram host gene expression - Divergent effects of P and type 1 fimbriae.
PLoS Pathog. 2019 Jun 10;15(6):e1007671. doi: 10.1371/journal.ppat.1007671. eCollection 2019 Jun.
10
Pili Assembled by the Chaperone/Usher Pathway in and .
EcoSal Plus. 2018 Mar;8(1). doi: 10.1128/ecosalplus.ESP-0007-2017.

本文引用的文献

1
PapG-dependent adherence breaks mucosal inertia and triggers the innate host response.
J Infect Dis. 2004 May 1;189(9):1734-42. doi: 10.1086/383278. Epub 2004 Apr 14.
2
Selection footprint in the FimH adhesin shows pathoadaptive niche differentiation in Escherichia coli.
Mol Biol Evol. 2004 Jul;21(7):1373-83. doi: 10.1093/molbev/msh136. Epub 2004 Mar 24.
4
The role of P fimbriae for Escherichia coli establishment and mucosal inflammation in the human urinary tract.
Int J Antimicrob Agents. 2003 Jun;21(6):605-21. doi: 10.1016/s0924-8579(02)00328-x.
5
Escherichia coli 83972 inhibits catheter adherence by a broad spectrum of uropathogens.
Urology. 2003 May;61(5):1059-62. doi: 10.1016/s0090-4295(02)02555-4.
6
Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli.
Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):17020-4. doi: 10.1073/pnas.252529799. Epub 2002 Dec 5.
7
The role of P fimbriae for Escherichia coli establishment and mucosal inflammation in the human urinary tract.
Int J Antimicrob Agents. 2002 Jun;19(6):522-38. doi: 10.1016/s0924-8579(02)00103-6.
8
Microbial minimalism: genome reduction in bacterial pathogens.
Cell. 2002 Mar 8;108(5):583-6. doi: 10.1016/s0092-8674(02)00665-7.
9
Virulence factors of uropathogens.
Curr Opin Urol. 2002 Jan;12(1):33-8. doi: 10.1097/00042307-200201000-00007.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验